Learn how multichain biotherapeutics overcome manufacturing challenges with advanced expression vector design.
Detailed price information for Molecular Partners Ag ADR (MOLN-Q) from The Globe and Mail including charting and trades.
The study by Reed et al. provides fundamental findings and convincing evidence defining the topological changes that occur during tumorigenesis. The findings enhance the understanding of stable ...
A neutrality index identifies mox-YG as a minimally cytotoxic protein, enabling ultra-high expression and uncovering key physiological consequences of protein burden.
DÜSSELDORF, Germany, Sept. 3, 2025 /PRNewswire/ -- LenioBio GmbH today announced a strategic partnership with AffinityAI, a Danish start-up pioneering AI-driven protein design. This collaboration ...
Kanazawa University, report in ACS Nano, how proteins in cells can be controllably activated through heating, an effect that ...
A team from the University of Illinois has uncovered surprising evolutionary links between the genetic code and tiny protein ...
The protein homeostasis (proteostasis) network (Balch et al, 2008), consisting of a collection of molecular chaperones, ...
News-Medical.Net on MSN
Novel biotechnical vector integrates viral and synthetic features for targeted cancer therapy
Gene therapy offers the possibility of addressing cancer at its molecular roots by targeting disease-causing genes rather than relying solely on surgery, chemotherapy, or radiotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback